Juanmin Zha
Suzhou, 215006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A multiparametric magnetic resonance imaging model incorporating the relative apparent diffusion coefficient for preoperative discrimination of triple-negative breast cancer.
Journal: American journal of translational research
Published: January 06, 2026
Correction: Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway.
Journal: Cell death & disease
Published: February 10, 2025
Crosstalk between the circadian clock, intestinal stem cell niche, and epithelial cell fate decision.
Journal: Genes & diseases
Published: February 02, 2024
Mesenchymal stromal cells confer breast cancer doxorubicin resistance by producing hyaluronan.
Journal: Oncogene
Published: June 06, 2023
Mechanisms underlying distinct subcellular localization and regulation of epithelial long myosin light-chain kinase splice variants.
Journal: The Journal of biological chemistry
Published: April 10, 2023
Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway.
Journal: Cell death & disease
Published: August 04, 2022
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice.
Journal: Drug design, development and therapy
Published: October 12, 2020
Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis.
Journal: Nature medicine
Published: February 19, 2018
Glucocorticoids transcriptionally regulate miR-27b expression promoting body fat accumulation via suppressing the browning of white adipose tissue.
Journal: Diabetes
Published: September 05, 2014
Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux.
Journal: Molecular biology of the cell
Published: August 09, 2013
11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
Journal: Endocrine journal
Published: June 14, 2013
Last Updated: 09/26/2026